- Clinical Trials
- April 2024
- 60 Pages
Global
From €1917EUR$2,000USD£1,602GBP
- Report
- April 2023
- 165 Pages
Global
From €7190EUR$7,500USD£6,008GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
- Book
- February 2024
- 592 Pages
Agomelatine is a drug used to treat mental disorders, such as major depressive disorder and generalized anxiety disorder. It is a melatonergic antidepressant, meaning it works by affecting the levels of melatonin in the brain. Agomelatine is thought to be more effective than traditional antidepressants, as it has fewer side effects and is better tolerated. It is also believed to be more effective in treating sleep disturbances associated with depression.
Agomelatine is available in many countries, including the United States, Canada, the United Kingdom, and Australia. It is available in both generic and brand-name forms.
The market for agomelatine is growing, as more people are turning to it as an alternative to traditional antidepressants. It is becoming increasingly popular as a treatment for mental disorders, as it is believed to be more effective and have fewer side effects.
Some companies in the agomelatine market include Lundbeck, Servier, and Mylan. Show Less Read more